these studies therefore indicate that the gh suppressing hormone somatostatin may be of clinical value as an adjunct to insulin in the treatment of patients with insulin-dependent diabetes mellitus and labile blood glucose control .
C0021641
insulin
C0011854
insulin-dependent diabetes mellitus